{"disease":{"id":"cancer-of-the-colon","name":"cancer of the colon"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06978595","title":"Primary Colorectal Signet Ring Cell Carcinoma and the Risk of Multiple Primary Gastrointestinal Malignancies","phase":"","overall_status":"COMPLETED","enrollment_count":8171,"lead_sponsor_name":"asmaa salama ibrahim","has_results":false},{"nct_id":"NCT03068052","title":"Behavioral Economic Incentives and Cancer Health Risk Assessment","phase":"NA","overall_status":"COMPLETED","enrollment_count":2000,"lead_sponsor_name":"University of Pennsylvania","has_results":false},{"nct_id":"NCT07319104","title":"Liquid Biopsy in Early Colorectal Lesions","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1000,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false},{"nct_id":"NCT06711939","title":"Vocorder Device Validation in Clinical Settings - Continuous Monitoring of Individuals (Vocorder Clinical Validation-VCV)","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":515,"lead_sponsor_name":"Mitera Hospital","has_results":false},{"nct_id":"NCT05669430","title":"A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":365,"lead_sponsor_name":"GV20 Therapeutics","has_results":false},{"nct_id":"NCT07070518","title":"Study of GV20-0251 in Participants With Solid Tumor Malignancies","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":350,"lead_sponsor_name":"GV20 Therapeutics","has_results":false},{"nct_id":"NCT03072095","title":"Colorectal Cancer Screening in a Community Health Setting","phase":"NA","overall_status":"COMPLETED","enrollment_count":281,"lead_sponsor_name":"University of Pennsylvania","has_results":false},{"nct_id":"NCT06791512","title":"mFOLFOX6 + Bevacizumab + PD-1 Monoclonal Antibody Vs. mFOLFOX6 in Locally Advanced pMMR/MSS CRC","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":166,"lead_sponsor_name":"Jun Huang","has_results":false},{"nct_id":"NCT05955196","title":"Test of CD47-SIRPα Inhibitors on the Immune Microenvironment Colon Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":115,"lead_sponsor_name":"Institut Paoli-Calmettes","has_results":false},{"nct_id":"NCT04668872","title":"Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation","phase":"","overall_status":"RECRUITING","enrollment_count":80,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":false},{"nct_id":"NCT05179837","title":"Endoscopic Optical Coherence Tomography for Screening and Diagnosis of Colorectal Precancerous and Malignant Polyps","phase":"NA","overall_status":"TERMINATED","enrollment_count":36,"lead_sponsor_name":"Washington University School of Medicine","has_results":true},{"nct_id":"NCT03328065","title":"Viewpoints on the Social Representations and Rationale Concerning the Choices of Patients, Doctors and Caregivers With Regard to the Management of Patients With Non-resectable Metastatic Cancer of the Colon, Stomach, Bile Ducts, Rectum, Pancreas or Lung, or Gastrointestinal Neuroendocrine Tumours","phase":"","overall_status":"TERMINATED","enrollment_count":36,"lead_sponsor_name":"Centre Hospitalier Universitaire Dijon","has_results":false},{"nct_id":"NCT03446157","title":"Palbociclib and Cetuximab in Metastatic Colorectal Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"UNC Lineberger Comprehensive Cancer Center","has_results":true},{"nct_id":"NCT02232152","title":"CPI-613 and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surgery","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":19,"lead_sponsor_name":"Wake Forest University Health Sciences","has_results":false},{"nct_id":"NCT01814501","title":"Panitumumab and Chemotherapy in Patients With Advanced Colorectal Cancer After Prior Therapy With Bevacizumab","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":16,"lead_sponsor_name":"John Hays","has_results":true},{"nct_id":"NCT01287130","title":"AZD6244 With Cetuximab for Solid Tumors and Colorectal Cancer","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT02110953","title":"Irinotecan-Eluting Beads in Treating Patients With Refractory Metastatic Colon or Rectal Cancer That Has Spread to the Liver","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":2,"lead_sponsor_name":"Fox Chase Cancer Center","has_results":false}],"total":17},"guidelines":[],"source":"Drug Landscape verified database"}